Back to Search
MICHAEL LOFFREDO, M.D.
M.D.
Plastic Surgery Physician
NPI: 1679653430IndividualAccepts Medicare
Specialties, Licenses & Credentials
Plastic Surgery PhysicianPrimary
Plastic Surgery
Code: 208200000X
48731(WI)
CMS Specialties
Education
RUTGERS R W JOHNSON MEDICAL SCHOOL (CAM/NEW BRUNS/PISC)
Class of 2004
Research & Publications (20)
Survival following radiation and androgen suppression therapy for prostate cancer in healthy older men: implications for screening recommendations.
PMID 19395186·Int J Radiat Oncol Biol Phys·2010
4-observational
Interval to testosterone recovery after hormonal therapy for prostate cancer and risk of death.
PMID 19395184·Int J Radiat Oncol Biol Phys·2009
4-observational
Generalized Bose-Fermi statistics and structural correlations in weighted networks.
PMID 19257403·Phys Rev Lett·2009
8-other
FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
PMID 19176318·Blood·2009
8-other
Persistent reduction of conduction velocity and myelinated axon damage in vibrated rat tail nerves.
PMID 19306323·Muscle Nerve·2009
7-preclinical
Maximum likelihood: extracting unbiased information from complex networks.
PMID 18764006·Phys Rev E Stat Nonlin Soft Matter Phys·2008
8-other
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial.
PMID 18212313·JAMA·2008
4-observational
Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer.
PMID 18980297·Cancer·2008
8-other
p53 protein expression status and recurrence in men treated with radiation and androgen suppression therapy for higher-risk prostate cancer: a prospective phase II Cancer and Leukemia Group B Study (CALGB 9682).
PMID 18291508·Urology·2008
3-trial
Tumor volume changes on 1.5 tesla endorectal MRI during neoadjuvant androgen suppression therapy for higher-risk prostate cancer and recurrence in men treated using radiation therapy results of the phase II CALGB 9682 study.
PMID 18037582·Int J Radiat Oncol Biol Phys·2008
3-trial
Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
PMID 17340594·Cancer·2007
2-rct
Prediagnostic prostate-specific antigen velocity and probability of detecting high-grade prostate cancer.
PMID 17382156·Urology·2007
8-other
A two-step approach for screening contacts of active tuberculosis.
PMID 17401721·Infection·2007
8-other
Correlation between exhaled nitric oxide and dietary consumption of fats and antioxidants in children with asthma.
PMID 17321576·J Allergy Clin Immunol·2007
8-other
Clinical non-instrumental evaluation of dysphagia.
PMID 18320836·Acta Otorhinolaryngol Ital·2007
8-other
A prospective evaluation of rectal bleeding after dose-escalated three-dimensional conformal radiation therapy using an intrarectal balloon for prostate gland localization and immobilization.
PMID 16584760·Urology·2006
3-trial
Predictors of mortality after prostate-specific antigen failure.
PMID 16682147·Int J Radiat Oncol Biol Phys·2006
3-trial
Perineural invasion associated with increased cancer-specific mortality after external beam radiation therapy for men with low- and intermediate-risk prostate cancer.
PMID 16765530·Int J Radiat Oncol Biol Phys·2006
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26 GLEASON ST
HYANNIS, MA 02601 - Phone
- (508) 771-8967
Quick Facts
- NPI
- 1679653430
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 22
- Publications
- 20
Are you this provider?
Claim Your Profile